SOAT1 and rheumatoid arthritis: Similarly, JAK/STAT signaling pathway has a non-negligible ability in chronic inflammation, which is also a potential therapeutic target for RA, and biological agents such as JAK inhibitors have been put into clinical application (Taylor et al., 2017).